It’s been nearly six months since Mithridion Inc., a Madison company developing drugs to treat Alzheimer’s disease, won the top prize in the Governor’s Business Plan Contest. And the impact of its victory continues.
“It has raised awareness. People know who we are and know something about what we’re trying to do, which is always very helpful,” said Trevor Twose, Mithridion’s chief executive officer.
Twose, who co-founded the company with UW-Madison associate professor Jeff Johnson, is in the midst of raising money from angel investors to help Mithridion take the technology from UW to the next stage: developing a drug candidate.